Skye Bioscience, Inc. logo

SKYESkye Bioscience, Inc.

SKYE Stock Price, Valuation & Chart | Skye Bioscience, Inc.

Compare

SKYE Historical price chart

SKYE Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization8.08M
PE Ratio-1.45
EPS-1.27
Trading Volume134.62K
Today's High/Low2.0/1.8
Dividend Yield0.00
52 Week High/Low39.92/1.64
Shares Outstanding4.39M
SKYE Financial Statement
SKYE Analyst ratings
SKYE Analysis & performance metrics

SKYE Company profile

Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The…

SKYE Management team

Management
Puneet S. Arora FACE, M.D., M.S.
Chief Medical Officer
Christopher G. Twitty Ph.D.
Chief Scientific Officer
Punit S. Dhillon B.A.CEO
President, Chief Executive Officer, Secretary & Director
Tu Diep M.Sc.COO
Chief Operating Officer
Brennen Brodersen J.D.
General Counsel
Kaitlyn Melanie Arsenault CPACFO
Chief Financial Officer
Total 6 executives

SKYE Frequently asked questions

What is Skye Bioscience, Inc. (SKYE) Stock Price?

Current stock price of Skye Bioscience, Inc. (SKYE) stock is $1.840. The stock price is +2.22% higher in the session. The intraday range can be seen from this page. Volume of Skye Bioscience, Inc. (SKYE) stock is 134.62K.

Last updated at 02 Sept 2026, 08:00 pm.

Why is the Skye Bioscience, Inc. (SKYE) stock price going up or down today?

The stock price of Skye Bioscience, Inc. (SKYE) can change with earnings, company news, and overall market sentiment. Skye Bioscience, Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Skye Bioscience, Inc. stock expensive at its current price?

Whether Skye Bioscience, Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for SKYE on this page is -1.45. EPS on this page is -1.27. Compare those figures with peers and growth expectations before deciding if the current Skye Bioscience, Inc. price is justified.

How has the stock price of Skye Bioscience, Inc. (SKYE) performed historically?

Historical performance for Skye Bioscience, Inc. (SKYE) is shown on the price chart on this page. Review multi-period moves alongside volume to see how SKYE reacted to past earnings and market events.

Should I buy Skye Bioscience, Inc. (SKYE) stock, at this price?

Buying Skye Bioscience, Inc. (SKYE) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.